Discover
MRKR
Marker Therapeutics, Inc.
1.45
2 x 1.07
2 x 1.88
bid
ask
-
0.02
1.36%
2 @ 04:00 PM
1.45 +0.00 (0.00%)
| Ytd | -2.68% | |
| 1y | -3.97% |
1.45
day range
1.50
0.81
52 week range
4.07
| Open | 1.46 | Prev Close | 1.47 | Low | 1.45 | High | 1.50 | Mkt Cap | 24.18M |
| Vol | 46.55K | Avg Vol | 87.21K | EPS | -0.55 | P/E | N/A | Forward P/E | -2.34 |
| Beta | 1.49 | Short Ratio | 1.55 | Inst. Own | 22.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.43 | 200-d Avg | 1.36 | 1yr Est | 19.00 |
| Income Statement | |||
| Operating Expenses | 4.07M | ||
| Research and Development Expense | 2.84M | ||
| Selling, General and Administrative Expense | 1.23M | ||
| Operating Income | -4.07M | ||
| Net Income | -3.18M | ||
| Net Income Common Stock | -3.18M | ||
| Net Income Common Stock (USD) | -3.18M | ||
| Consolidated Income | -3.18M | ||
| Earnings per Basic Share | -0.16 | ||
| Earnings per Basic Share (USD) | -0.16 | ||
| Earnings per Diluted Share | -0.16 | ||
| Earning Before Interest & Taxes (EBIT) | -3.18M | ||
| Earning Before Interest & Taxes (USD) | -3.18M | ||
| Weighted Average Shares | 19.31M | ||
| Weighted Average Shares Diluted | 19.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 15.64M | ||
| Cash and Equivalents (USD) | 15.64M | ||
| Trade and Non-Trade Receivables | 1.38M | ||
| Current Assets | 17.43M | ||
| Total Assets | 17.43M | ||
| Current Liabilities | 3.64M | ||
| Total Liabilities | 3.64M | ||
| Accumulated Retained Earnings (Deficit) | -462.36M | ||
| Shareholders Equity | 13.80M | ||
| Shareholders Equity (USD) | 13.80M | ||
| Deferred Revenue | 723.14K | ||
| Trade and Non-Trade Payables | 2.91M | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.40M | ||
| Net Cash Flow from Operations | -1.40M | ||
| Share Based Compensation | 178.42K | ||